Outset Medical, Inc.OMNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -3.41% | +5.62% | +14.72% | +2.67% | -2.01% |
| Gross Profit Growth | +39.35% | +34.70% | +21.31% | +18.02% | +13.81% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.93% | +2.06% | +413.00% | +428.20% | +421.72% |
| Weighted Average Shares Diluted Growth | +1.93% | +2.06% | +413.00% | +428.20% | +421.72% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +8.00% | +1.13% | +2.26% | -3.79% | -20.47% |
| Inventory Growth | +20.67% | -0.12% | -15.18% | -19.77% | -19.83% |
| Asset Growth | -12.11% | -13.01% | -8.18% | -5.34% | -4.10% |
| Book Value per Share Growth | -78.59% | +78.58% | -56.02% | -43.64% | -9.27% |
| Debt Growth | +48.22% | -51.52% | -51.35% | -50.55% | -48.22% |
| R&D Expense Growth | -37.05% | -56.35% | -45.66% | -33.95% | -35.94% |
| SG&A Expenses Growth | -24.02% | -32.44% | -23.92% | -13.69% | +0.35% |